Ask AI
ASCENT03 Safety Analysis
ASCENT-03: Safety Analysis of Sacituzumab Govitecan vs Chemotherapy in Previously Untreated Patients With Advanced TNBC Ineligible for PD-(L)1 Inhibitors

Released: December 15, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 15, 2025